Susceptibility to six antibiotics of group B streptococci isolated from cerebrospinal fluid.
64 clinical isolates of group B streptococci from cerebrospinal fluids of neonates were tested for susceptibility to 6 antibiotics. The strains were obtained in The Netherlands during 7 years. The usefulness of the generally recommended initial therapy, a combination of ampicillin and gentamicin, is supported.
D000667:Ampicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D008581:Meningitis / Q000134:cerebrospinal fluid / Q000188:drug therapy* / Q000382:microbiology; D010403:Penicillin Resistance; D013290:Streptococcal Infections / Q000134:cerebrospinal fluid / Q000188:drug therapy* / Q000382:microbiology; D013292:Streptococcus agalactiae / Q000187:drug effects* / Q000302:isolation & purification
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D000667:Ampicillin